NCT02874092View on ClinicalTrials.gov

Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

April 19, 2019

Study Completion Date

June 19, 2019

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Ticagrelor

DRUG

MTX therapy

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02874092 - Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter